- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Abbisko Cayman Ltd (2256)
Abbisko Cayman Ltd stock price live, this page displays HK 2256 stock exchange data. View the 2256 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Abbisko Cayman Ltd real time stock price chart below.
What Is the Abbisko Cayman Ltd Stock Price Today?
The Abbisko Cayman Ltd stock price today is 7.91.
What Is the Stock Symbol for Abbisko Cayman Ltd?
The stock symbol for Abbisko Cayman Ltd is "2256."
What Stock Exchange Does Abbisko Cayman Ltd Trade On?
Abbisko Cayman Ltd is listed and trades on the Hong Kong stock exchange.
Is Abbisko Cayman Ltd a Good Stock to Buy?
Determining whether Abbisko Cayman Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 2256 quote. (ISIN: KYG0028A1085)
What Is the Abbisko Cayman Ltd Stock Price Today?
The Abbisko Cayman Ltd stock price today is 7.91.
What Is the Stock Symbol for Abbisko Cayman Ltd?
The stock symbol for Abbisko Cayman Ltd is "2256."
What Stock Exchange Does Abbisko Cayman Ltd Trade On?
Abbisko Cayman Ltd is listed and trades on the Hong Kong stock exchange.
Is Abbisko Cayman Ltd a Good Stock to Buy?
Determining whether Abbisko Cayman Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 2256 quote. (ISIN: KYG0028A1085)
Hong Kong
Currency in HKD
7.91
-0.59(-6.94%)
Closed
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
7.88
8.75
52 wk Range
2.71
8.85
2256 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Unusual trading volume
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
7.888.75
52 wk Range
2.718.85
Abbisko Cayman Ltd is currently considered to be trading at Fair valueExplore our list of undervalued stocks for hidden opportunities
Abbisko Cayman Ltd is not on our AI-picked strategiesExplore current and previous stocks selected by AI
Try Warren AI research assistant for instant insights on Abbisko Cayman LtdFrom metrics, to news, charts, and even a SWOT analysis - you can ask anything!
What you should know about Abbisko Cayman LtdHolds more cash than debt on its balance sheetTrading at a high earnings multiple
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
2256 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceFair Price
Upside
Technical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
11.02
Upside
+39.36%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a high earnings multiple
No news in this category
Looks like there are no results in this news category
Abbisko Cayman Company Profile
Abbisko Cayman Limited engages in the discovering and developing small molecule oncology therapies in China. The company develops pimicotinib, which is in Phase III clinical trial for treatment of tenosynovial giant cell tumor; Irpagratinib that is in Phase II clinical trial for treatment of liver cancer; Fexagratinib, which is in Phase II clinical trial for the treatment of urothelial carcinoma; ABSK043 that is in Phase I clinical trial for treatment of multiple tumors; ABSK061, ABSK121, and ABSK051, which is in Phase I clinical trial for treatment of solid tumors; ABSK112 that is in Phase I of clinical trial for treatment of non-small cell lung cancer; ABSK012, which is in Phase I clinical trial for treatment of soft tissue sarcoma. It is involved in technical services and consultation. The company was founded in 2016 and is headquartered in Shanghai, the People’s Republic of China.
Compare 2256 to Peers and Sector
Metrics to compare | 2256 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship2256PeersSector | |
|---|---|---|---|---|
P/E Ratio | 163.0x | −13.2x | −0.5x | |
PEG Ratio | 1.54 | 0.07 | 0.00 | |
Price/Book | 2.4x | 4.1x | 2.6x | |
Price / LTM Sales | 9.2x | 13.8x | 3.0x | |
Upside (Analyst Target) | 21.4% | 46.6% | 55.2% | |
Fair Value Upside | Unlock | −2.0% | 9.7% | Unlock |
Analyst Ratings
6 Buy
0 Hold
0 Sell
Ratings:
6 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 11.02
(+39.36% Upside)
FAQ
What Is the Abbisko Cayman (2256) Stock Price Today?
The Abbisko Cayman stock price today is 7.91.
What Stock Exchange Does Abbisko Cayman Trade On?
Abbisko Cayman is listed and trades on the Hong Kong stock exchange.
What Is the Stock Symbol for Abbisko Cayman?
The stock symbol for Abbisko Cayman is "2256."
What Is the Abbisko Cayman Market Cap?
As of today, Abbisko Cayman market cap is 4.95B.
What is Abbisko Cayman Earnings Per Share?
The Abbisko Cayman EPS is 0.045.
From a Technical Analysis Perspective, Is 2256 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.